Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma.

Nature communications·2026
Same author

Correction: Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications.

Gene therapy·2026
Same author

An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma.

Molecular therapy. Oncology·2025
Same author

Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications.

Gene therapy·2025
Same author

Transforming Molecular Life Sciences Education: Past, Current, and Future Insights and Practices.

Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology·2025
Same author

Durable tissue-specific transgene expression in newborn mice following intraperitoneal delivery of non-cytotoxic HSV vectors.

Molecular therapy. Methods & clinical development·2025

Related Experiment Video

Updated: Jun 11, 2025

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

36.0K

Viral vectors for gene delivery to the central nervous system.

Selene Ingusci1, Bonnie L Hall1, William F Goins1

  • 1Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA, United States.

Handbook of Clinical Neurology
|September 28, 2024
PubMed
Summary

Gene therapy offers promise for brain diseases by delivering therapeutic genes to the central nervous system (CNS). Advances in viral vectors are improving safety and targeting for genetic disorders.

Keywords:
AAVBrain disordersGene regulationGene therapyHSV-1Viral vectors

More Related Videos

Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction
08:11

Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction

Published on: August 25, 2017

11.5K
Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
10:15

Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction

Published on: September 15, 2014

59.1K

Related Experiment Videos

Last Updated: Jun 11, 2025

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

36.0K
Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction
08:11

Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction

Published on: August 25, 2017

11.5K
Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
10:15

Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction

Published on: September 15, 2014

59.1K

Area of Science:

  • Neuroscience
  • Genetics
  • Biotechnology

Background:

  • Brain diseases with genetic origins are a significant therapeutic challenge due to the central nervous system's (CNS) complexity.
  • Genetic intervention is becoming more feasible with increased understanding of molecular genetics.
  • Developing effective gene vectors and delivery methods for the CNS remains difficult.

Purpose of the Study:

  • To review prominent viral vector systems for gene therapy in CNS disorders.
  • To highlight challenges and improvements in vector design for brain applications.
  • To discuss achieving safe, targeted, and effective gene expression in the brain.

Main Methods:

  • Review of viral vector development over the past 40 years for CNS gene delivery.
  • Analysis of vector systems approaching clinical application for neurological diseases.
  • Evaluation of vector characteristics including tropism, safety, and expression levels.

Main Results:

  • Various viral vectors have been developed, primarily targeting neurons.
  • Improvements focus on achieving specific cell-type distribution, regional targeting, and controlled transgene expression.
  • Key challenges include vector safety, minimizing toxicity, and avoiding inflammatory responses.

Conclusions:

  • Gene therapy holds potential for treating genetic brain disorders.
  • Ongoing advancements in viral vector technology are crucial for clinical success.
  • Optimized vector design is essential for safe and effective CNS gene delivery.